CVD Risk Increased for Adolescent, Young Adult Cancer Survivors
MONDAY, Dec. 5, 2022 (HealthDay News) — Adolescent and young adult (AYA) cancer survivors...
Read More
Hematology/Oncology
Legalization of Medical Marijuana Beneficial for Cancer Patients
MONDAY, Dec. 5, 2022 (HealthDay News) — Legalization of medical marijuana is associated with...
Read More
Cryoablation More Effective for Some Early-Stage Renal Cell Carcinomas
MONDAY, Dec. 5, 2022 (HealthDay News) — For patients with early-stage renal cell carcinoma,...
Read More
More Biosimilars Marketed in Germany, Switzerland Than U.S.
FRIDAY, Dec. 2, 2022 (HealthDay News) — More biosimilars have been marketed in Germany and...
Read More
Preexisting Type 2 Diabetes Tied to Later Stage of Cancer Diagnosis
FRIDAY, Dec. 2, 2022 (HealthDay News) — Individuals with type 2 diabetes face an increased...
Read More
Risk for Breast Cancer Up for Women With Benign Breast Disease
FRIDAY, Dec. 2, 2022 (HealthDay News) — Women with benign breast disease have an elevated...
Read More
Personalized Counseling May Overcome Non-Follow-Up After Positive FIT Test
FRIDAY, Dec. 2, 2022 (HealthDay News) — Lack of knowledge and decision-making difficulties...
Read More
Awareness of the Link Between Alcohol, Cancer Is Low
THURSDAY, Dec. 1, 2022 (HealthDay News) — Awareness of the link between alcohol and cancer...
Read More
Six Additional Weeks of Rivaroxaban Reduces Recurrent VTE
WEDNESDAY, Nov. 30, 2022 (HealthDay News) — For patients with isolated distal deep venous...
Read More
Convection-Enhanced Delivery of Topotecan Active in Glioblastoma
WEDNESDAY, Nov. 30, 2022 (HealthDay News) — A subcutaneously implanted, catheter-pump system...
Read More
Melanoma Diagnosis Linked to Increased Risk of Prostate Cancer
TUESDAY, Nov. 29, 2022 (HealthDay News) — Melanoma diagnosis is associated with increased...
Read More
Risk of Uterine Diseases, Cancers Up With Tamoxifen Treatment
TUESDAY, Nov. 29, 2022 (HealthDay News) — Tamoxifen treatment is associated with increased...
Read More
Coping Strategies Linked to Distress, QOL in Caregivers of Stem Cell Recipients
TUESDAY, Nov. 29, 2022 (HealthDay News) — For caregivers of patients with hematologic...
Read More
QOL Up With Pembrolizumab Versus Ipilimumab, HDI in Resected Melanoma
MONDAY, Nov. 28, 2022 (HealthDay News) — For patients with high-risk resected melanoma,...
Read More
FDA Approves First Gene Therapy for Adults With Hemophilia B
MONDAY, Nov. 28, 2022 (HealthDay News) — The U.S. Food and Drug Administration has approved...
Read More
High Sugar Consumption Affects Aging in Childhood Cancer Survivors
MONDAY, Nov. 28, 2022 (HealthDay News) — Survivors of childhood cancer who consume more...
Read More
Belantamab Mafodotin for Relapsed/Refractory Multiple Myeloma
The Food and Drug Administration (FDA) granted accelerated approval to the drug belantamab...
Read More
BRAF in Cancer Therapy: Molecular Mechanisms and Pathways
Because BRAF activating mutations have been found in so many different types of cancer, there has...
Read More
Pancreatic Cancer Immunotherapy: What We Know and What We Hope for
In spite of recent advances, pancreatic ductal adenocarcinoma (PDAC) is still extremely difficult...
Read More
Adherence to Quality Indicators Low in Chronic Myeloid Leukemia
WEDNESDAY, Nov. 23, 2022 (HealthDay News) — For newly diagnosed chronic-phase chronic...
Read More